Tag #Pancreatitis

Showing 1 to 4 of 4 results

dailymail.co.uk

🌐 85% Global Worthiness

Jul 3, 16:14

Failure to Conduct Blood Tests Before Prescribing Mounjaro Risks Deadly Organ Failure for Thousands

A nurse warned that thousands of NHS patients using the weight-loss jab Mounjaro are at risk of deadly organ failure because GPs are not conducting mandatory blood tests to screen for underlying health issues that could worsen the drug's side effects, including pancreatitis and severe dehydration, b...

Failure to Conduct Blood Tests Before Prescribing Mounjaro Risks Deadly Organ Failure for Thousands

A nurse warned that thousands of NHS patients using the weight-loss jab Mounjaro are at risk of deadly organ failure because GPs are not conducting mandatory blood tests to screen for underlying health issues that could worsen the drug's side effects, including pancreatitis and severe dehydration, b...

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences of GPs failing to perform blood tests before prescribing Mounjaro, and what is the potential impact on patients?

Thousands of patients using the weight-loss injection Mounjaro may be at risk of deadly organ failure due to GPs' failure to conduct mandatory blood tests before prescribing the drug. These tests can detect underlying conditions like high triglycerides, which increase pancreatitis risk, and uncontrolled diabetes, increasing severe dehydration risk. Both conditions can lead to organ failure.

news.sky.com

🌐 85% Global Worthiness

Jun 26, 10:15

UK Weight-Loss Injections Linked to Pancreatitis Cases

Over a million people in the UK have used weight loss and diabetes jabs, with the Medicines and Healthcare products Regulatory Agency (MHRA) reporting 294 cases of pancreatitis (inflammation of the pancreas) linked to these drugs, including five deaths. A new study will investigate genetic links.

UK Weight-Loss Injections Linked to Pancreatitis Cases

Over a million people in the UK have used weight loss and diabetes jabs, with the Medicines and Healthcare products Regulatory Agency (MHRA) reporting 294 cases of pancreatitis (inflammation of the pancreas) linked to these drugs, including five deaths. A new study will investigate genetic links.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate implications of the reported pancreatitis cases linked to weight-loss injections in the UK?

Over one million Britons have used weight-loss and diabetes injections linked to 181 pancreatitis cases and five deaths. The Medicines and Healthcare products Regulatory Agency (MHRA) notes that while there's no direct causal link, a new study will investigate genetic predispositions to this side effect. This highlights the importance of personalized medicine.

elpais.com

🌐 75% Global Worthiness

Jul 3, 07:15

MHRA Investigates Link Between GLP-1 Drugs and Pancreatitis

The UK's MHRA is investigating a possible link between GLP-1 weight-loss drugs and pancreatitis, prompting a review of 560 cases, although current data doesn't indicate rates exceeding those in clinical trials; experts warn against unregulated use.

MHRA Investigates Link Between GLP-1 Drugs and Pancreatitis

The UK's MHRA is investigating a possible link between GLP-1 weight-loss drugs and pancreatitis, prompting a review of 560 cases, although current data doesn't indicate rates exceeding those in clinical trials; experts warn against unregulated use.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the UK MHRA's investigation into the link between GLP-1 drugs and pancreatitis?

The UK's MHRA is investigating a potential link between GLP-1 receptor agonists (like Ozempic) and pancreatitis, prompting a review of 560 pancreatitis cases in users. While the investigation is ongoing, preliminary data doesn't show pancreatitis rates exceeding those observed in clinical trials (less than 0.5% for semaglutide).

dailymail.co.uk

🌐 85% Global Worthiness

Jan 20, 19:08

Weight-Loss Drugs Double Pancreatitis Risk: Major Study

A Washington University study of over 2 million diabetes patients found that weight-loss drugs like Ozempic doubled the risk of pancreatitis and increased risks of nausea/vomiting (30%), arthritis (11%), headaches (10%), and sleep disturbances (12%), despite also showing benefits in cardiovascular a...

Weight-Loss Drugs Double Pancreatitis Risk: Major Study

A Washington University study of over 2 million diabetes patients found that weight-loss drugs like Ozempic doubled the risk of pancreatitis and increased risks of nausea/vomiting (30%), arthritis (11%), headaches (10%), and sleep disturbances (12%), despite also showing benefits in cardiovascular a...

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the long-term implications of the widespread use of GLP-1RA drugs, given the newly discovered risks and the need for ongoing monitoring?

While offering significant benefits like reduced cardiovascular and neurocognitive risks, the study highlights potentially serious side effects of GLP-1RA weight-loss drugs, necessitating close monitoring of pancreatitis and kidney function. The 'skyrocketing' popularity of these drugs demands further investigation into long-term effects and potential risks.

Showing 1 to 4 of 4 results